SecBot SecBot
8-K ·Filed May 5, 2026

ARDT

Ardent Health, Inc.
BULLISH
Impact 6/10
Horizondays Processed5mo ago SEC0001628280-26-030552
8-K Item 2.02: Earnings release
Actionable Insight ▲ Bullish

The strong Q1 beat and reaffirmed guidance support a positive near-term outlook. However, monitor GAAP net income trends and payor/Exchange dynamics. Expect the stock to react favorably to the EPS beat and EBITDA acceleration.

DirectionBullish
Confidencehigh
Horizondays
Final — all horizons settled through T+60d
ARDT ▲ +13.87% at T+60d
LONG call ✓ call won +13.87% · α vs SPY +11.81% · entry $9.37 → $10.67
Entry = T+0 close
May 5, 2026
via day close
T+1d
0.00%
call 0.00% · α +0.33%
$9.37
settled 6mo ago
T+5d
+7.47%
call +7.47% · α +6.34%
$10.07
settled 6mo ago
T+20d
-16.44%
call -16.44% · α -19.22%
$7.83
settled 5mo ago
T+60d
+13.87%
call +13.87% · α +11.81%
$10.67
settled 3mo ago

Price Chart

Loading chart...

Executive Summary

Ardent Health reported Q1 2026 revenue of $1.602B (+7% YoY) and adjusted EBITDA of $124M (+26.3%), with GAAP diluted EPS of $0.28 beating the $0.18 consensus by 56%. The company reaffirmed its 2026 revenue and adjusted EBITDA guidance, signaling confidence in its operational trajectory despite GAAP net income slightly declining.

Key Financial Metrics

EPS
$0.28
est $0.18 · +55.6%
Revenue
$1.6B
+7.0% YoY
Rating
strong beat
Guidance
$6,400-$6,700 million
maintained

Key Facts

  • Revenue $1.602B, +7.0% YoY
  • Adjusted EBITDA $124M, +26.3% YoY
  • GAAP diluted EPS $0.28 vs consensus $0.18 (beat +55.6%)
  • Reaffirmed FY2026 guidance: revenue $6.4-6.7B, EBITDA $485-535M
  • Adjusted admissions +2.0%, net patient service revenue per adjusted admission +5.5%
  • Operating cash flow used $60M vs $25M in prior year quarter

Financial Impact

Adjusted EBITDA grew 26% YoY, surpassing revenue growth; EPS beat consensus by $0.10 per share.

revenueadjustedEBITDAeps

Risk Factors

  • Payor denial pressures and professional fee inflation
  • Exchange market disruption from subsidy expiration
  • Seasonal volume swings due to weather or respiratory season

Market Snapshot

Exchange
NYSE
Sector
Services-General Medical & Surgical Hospitals, NEC
Analyst Consensus
68% bullish (19 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 6 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001628280-26-030552
Document: ardt-20260505.htm0001628280-26-030552
Document: 0001628280-26-030552-index-headers.html0001628280-26-030552
Document: 0001628280-26-030552-index.html0001628280-26-030552
Document: 0001628280-26-030552.txt0001628280-26-030552
8-K Data (Synthetic)0001628280-26-030552
9 reports for ARDT
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for ARDT — sortable, filterable
TypeNow
Oct 23, 2026
4d ago
8-K
BEARISH ★ 5/10
$12.18 $11.83▲ +2.87%▲ +3.43%$11.83 (+2.87%)
Aug 20, 2026
9w ago
144
NEUTRAL ★ 2/10
$10.99 $11.25▲ +2.37%▲ +2.66%$11.83 (+7.64%)
Aug 15, 2026
10w ago
Institutional Cluster
BULLISH ★ 5/10
$10.89 $10.93▲ +0.37%▲ +1.04%$11.83 (+8.63%)
Jun 30, 2026
17w ago
8-K
NEUTRAL ★ 3/10
$10.13 $10.76▲ +6.22%▲ +6.35%$11.83 (+16.78%)
Jun 11, 2026
19w ago
Institutional Cluster
NEUTRAL ★ 3/10
$9.67 $9.35▼ −3.31%▼ −3.85%$11.83 (+22.34%)
Jun 2, 2026
21w ago
8-K
MIXED ★ 5/10
$7.83 $8.60▲ +9.83%▲ +9.43%$11.83 (+51.09%)
May 5, 2026
25w ago
8-K
BULLISH ★ 6/10
$9.37 $9.37· 0.00%▲ +0.33%$11.83 (+26.25%)
Apr 8, 2026
28w ago
DEFA14A
NEUTRAL ★ 2/10
$9.53 $9.40▼ −1.36%▼ −1.30%$11.83 (+24.13%)
Mar 4, 2026
33w ago
8-K
MIXED ★ 6/10
$9.44 $8.90▼ −5.72%▼ −4.41%$11.83 (+25.32%)
Showing 9 of 9

US Market Status

Market Closed — Opens Wed (< 1m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published May 5, 2026